Table 3.
Variable | CCS | STEMI | NSTEMI | UA | p-Value |
---|---|---|---|---|---|
N | 206 | 107 | 59 | 32 | - |
Age (years) | 64.3 (30.9–93.3) | 59.8 (36.3–88.4) | 61.5 (38.0–86.4) | 66.5 (33.6–80.8) | <0.001 |
BMI (kg/m2) | 27.8 (16.1–47.4) | 27.0 (16.9–44.6) | 27.9 (20.8–36.1) | 26.4 (22.2–34.6) | 0.24 |
Previous MI (no/yes) | 130/76 | 60/47 | 26/33 | 20.12 | 0.06 |
CASSS (0/1/2/3) | 62/43/57/44 | 3/50/31/23 | 5/17/19/18 | 2/5/11/14 | <0.001 |
Total cholesterol (mg/dL) | 164 (96–327) | 180 (98–320) | 165 (70–334) | 144 (81– 303) | 0.002 |
High-density lipoprotein (mg/dL) | 46.0 (14.6–113) | 44.3 (20.5–92.9) | 39.3 (22.8–73.2) | 42.8 (19.5–65.8) | <0.001 |
Low-density lipoprotein (mg/dL) | 86.2 (22.3–258) | 107 (38.2–214) | 96.4 (23.5–244) | 75.5 (32.9–228) | <0.001 |
Triglycerides (mg/dL) | 113 (37–438) | 108 (55–368) | 115 (44–457) | 109 (43–252) | 0.49 |
Hyperlipidemia (no/yes) | 91/115 | 35/72 | 23/36 | 21/11 | 0.008 |
Hypertension (no/yes) | 44/162 | 20/87 | 8/51 | 1/31 | 0.07 |
Smoking (no/ex-smokers/yes) | 119/37/50 | 45/7/55 | 27/3/29 | 22/6/4 | <0.001 |
Type 2 diabetes mellitus (yes/pre-diabetes/no) | 116/10/79 | 75/3/28 | 37/4/18 | 18/0/14 | 0.15 |
Monocytes (thousand cells/µL) | 0.73 (0.30–1.76) | 0.80 (0.31–1.63) | 0.68 (0.40–1.65) | 0.76 (0.31–1.54) | 0.06 |
MHR | 0.015 (0.01–0.06) | 0.018 (0.01–0.06) | 0.017 (0.01–0.05) | 0.018 (0.01–0.07) | 0.009 |
Serum 25(OH)D (ng/mL) | 16.8 (4.1–46.9) | 14.1 (4.0–42.9) | 14.0 (5.0–37.6) | 17.6 (4.3–36.7) | 0.035 |
Examination date (May–October/November–April) | 51/155 | 28/79 | 17/42 | 10/22 | 0.84 |
Data presented as number or median (range). CCS—chronic coronary syndrome; BMI—body mass index; MI—myocardial infarction; CASSS—Coronary Artery Surgery Study Score; MHR—monocyte-to-high-density lipoprotein ratio; prevalence differences between groups were determined using Pearson’s chi-squared test or Fisher’s exact test; Kruskal–Wallis one-way ANOVA followed by Dunn’s post hoc test for multiple comparisons was used to determine the dependence between groups.